搜索临床试验以:Camrelizumab、阿帕替尼和 Nab-紫杉醇
总计7993个结果
-
Fujian Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.; SunWay Biotech Co., LTD.尚未招聘肝转移 | 恶性黑色素瘤
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.尚未招聘
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityGuangdong Provincial People's Hospital; Third Affiliated Hospital, Sun Yat-Sen University招聘中
-
Biocad招聘中
-
Guangdong Association of Clinical Trials尚未招聘
-
The First Affiliated Hospital of Xiamen University未知Locally Advanced or Metastatic Gastric Adenocarcinoma中国
-
Fujian Medical University尚未招聘
-
Peking Union Medical College Hospital完全的
-
The First Affiliated Hospital of Zhengzhou University招聘中
-
Jiangsu HengRui Medicine Co., Ltd.终止
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Shandong UniversityThe Affiliated Hospital of Qingdao University; Qianfoshan Hospital; The Second Hospital of Shandong...招聘中
-
Peking UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Shanghai Cell Therapy Group Co.,LtdShanghai Mengchao Cancer Hospital尚未招聘
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.招聘中
-
PD Dr. med. Volker HeinemannUniversity of Cologne; Technical University of Munich未知
-
Beijing Friendship Hospital未知
-
The First Affiliated Hospital of Zhengzhou UniversityJiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Chinese PLA General Hospital招聘中
-
Ying Lin招聘中Her-2 阴性乳腺癌 | HRR基因突变中国
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中BCLC 分类中的 C 期肝细胞癌中国
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.尚未招聘
-
Tongji HospitalZhejiang Cancer Hospital; Xiangya Hospital of Central South University; Beijing Friendship Hospital 和其他合作者尚未招聘
-
Hebei Medical University尚未招聘
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.未知
-
Fudan University主动,不招人
-
Zhongshan Hospital Xiamen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人根治性切除或消融后复发风险高的肝细胞癌 (HCC) 患者的辅助治疗中国